04:08 PM EDT, 06/11/2024 (MT Newswires) -- Elizabeth Crowley, Senior Vice President, Chief Product Development Officer, on June 07, 2024, sold 15,000 shares in Celldex Therapeutics ( CLDX ) for $525,873. Following the Form 4 filing with the SEC, Crowley has control over a total of 9,074 shares of the company, with 9,074 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/744218/000141588924016345/xslF345X03/form4-06112024_080653.xml